Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment

Current and Proposed Biomarkers of Anthracycline Cardiotoxicity in Cancer: Emerging Opportunities in Oxidative Damage and Autophagy

(2012) J. S. Dickey et al.   CURRENT MOLECULAR MEDICINE

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening

(2012) Sui-Lin Mo et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Challenges in design and characterization of ligand-targeted drug delivery systems

(2012) Silvia Muro   JOURNAL OF CONTROLLED RELEASE

Finding the optimal balance: Challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems

(2012) Felix Kratz et al.   JOURNAL OF CONTROLLED RELEASE

Development of Novel Bisphosphonate Prodrugs of Doxorubicin for Targeting Bone Metastases That Are Cleaved pH Dependently or by Cathepsin B: Synthesis, Cleavage Properties, and Binding Properties to Hydroxyapatite As Well As Bone Matrix

(2012) Katrin Hochdörffer et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin

(2012) Thibaut Legigan et al.   JOURNAL OF MEDICINAL CHEMISTRY

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role

(2012) Krista S. Crider et al.   Advances in Nutrition

Nanoparticle Delivery of Cancer Drugs

(2011) Andrew Z. Wang et al.   Annual Review of Medicine

Cyclodextrin-based inclusion complexation bridging supramolecular chemistry and macromolecular self-assembly

(2011) Guosong Chen et al.   CHEMICAL SOCIETY REVIEWS

Ligand- and Protein-Based Modeling Studies of the Inhibitors of Human Cytochrome P450 2D6 and a Virtual Screening for Potential Inhibitors from the Chinese Herbal Medicine, Scutellaria baicalensis (Huangqin,Baikal Skullcap)

(2011) Sui-Lin Mo et al.   COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING

Possibilities to increase the effectiveness of doxorubicin in cancer cells killing

(2011) Veronika Hanušová et al.   DRUG METABOLISM REVIEWS

Anthracycline cardiotoxicity

(2011) Pierantonio Menna et al.   Expert Opinion On Drug Safety

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

(2011) Twan Lammers et al.   JOURNAL OF CONTROLLED RELEASE

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

(2011) Rene Kizek et al.   PHARMACOLOGY & THERAPEUTICS

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Host-Guest Complexation Studied by Fluorescence Correlation Spectroscopy: Adamantane–Cyclodextrin Inclusion

(2010) Daniel Granadero et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pharmacophore mapping, molecular docking and QSAR studies of structurally diverse compounds as CYP2B6 inhibitors

(2010) Partha Pratim Roy et al.   MOLECULAR SIMULATION

Strategies in the design of nanoparticles for therapeutic applications

(2010) Robby A. Petros et al.   NATURE REVIEWS DRUG DISCOVERY

The global burden of cancer: priorities for prevention

(2009) M. J. Thun et al.   CARCINOGENESIS

A change of strategy in the war on cancer

(2009) Robert A. Gatenby   NATURE

Structural insights into hedgehog ligand sequestration by the human hedgehog-interacting protein HHIP

(2009) Benjamin Bishop et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Targeted drug delivery via folate receptors

(2008) Xiaobin Zhao et al.   Expert Opinion on Drug Delivery